Evidence map›Paper›PMID 37287223›Full record

ArticleBritish journal of neurosurgery2025

Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.

Sepideh Mokhtari, Noah C Peeri, Andre Beer-Furlan, Mark D Anderson, Sajeel Chowdhary, Renato V LaRocca, Aaron G Mammoser, L Burt Nabors, Jeffrey J Olson, Reid C Thompson and 3 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in British journal of neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 3 countries.

Sepideh MokhtariDepartment of Neuro-Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa FL, USA.
Noah C PeeriDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andre Beer-FurlanDepartment of Neuro-Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa FL, USA.
Mark D AndersonDepartment of Neuro-Oncology, University of Mississippi Medical Center, Jackson, MS, USA.
Sajeel ChowdharyNeuro-Oncology Program, Lynn Cancer Institute, Boca Raton, FL, USA.
Renato V LaRoccaNorton Cancer Institute, Louisville, KY, USA.
Aaron G MammoserDepartment of Neurosurgery, LSU Health Sciences Center, New Orleans, LA, USA.
L Burt NaborsNeuro-Oncology Program, University of Alabama at Birmingham, Birmingham, AL, USA.
Jeffrey J OlsonDepartment of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA.
Reid C ThompsonDepartment of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Zachary J ThompsonDepartment of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Yessica C MartinezDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Kathleen M EganDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
Moffitt Cancer Center · USEmory University · USJackson Memorial Hospital · USLouisiana State University Health Sciences Center New Orleans · USLynn University · USMemorial Sloan Kettering Cancer Center · USNorton University · KHUniversity of Alabama at Birmingham · USVanderbilt University Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
Oncology-focused Postdoctoral Training in Care Delivery and Symptom Science (OPTICS)T32CA275764 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI JONINE L. BERNSTEIN, JUN J MAO · 2023 to 2026
$1.8M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA076292NCI NIH HHS T32 CA275764
6 · The paper itself

Abstract

purposeWe studied 571 patients with intracranial meningioma for clinical characteristics and tumor location associated with high grade meningioma (WHO II/III). MATERIALS AND

methodsPatients were participants in a multicentre epidemiologic study of risk factors for primary brain tumors including meningioma recruited from September 2005 to November 2019. We included patients 18 or older with a recent diagnosis of a primary intracranial meningioma of any subtype (ICD9/10: 9530-0, 9531-0, 9532-0, 9537-0, 9533-0, 9534-0, 9530-0, 9538-1, 9538-3) who were enrolled at neuro-oncology and neuro-surgery clinics in the southeastern U.S.

resultsThe median patient age was 58 years (IQR: 48-68) and the majority of patients were female (

conclusionThese findings may shed additional light on the underlying pathogenesis of meningioma.

Indexed as

Meningeal NeoplasmsMeningiomaAdultAgedFemaleHumansMaleMiddle AgedNeoplasm GradingRisk Factorsclinical serieshigh-gradeMeningiomaskull-based

Identifiers

PMID37287223
PMCPMC12142684
OpenAlexW4379769410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.